The association between inflammation-related genes and serum androgen levels in men: The prostate, lung, colorectal, and ovarian study

Prostate

Volumn 72, Issue 1, 2012, Pages 65-71

  Meyer, Tamra E ^a   Chu, Lisa W ^a   Li, Qizhai ^a,b   Yu, Kai ^a   Rosenberg, Philip S ^a   Menashe, Idan ^a   Chokkalingam, Anand P ^c   Quraishi, Sabah M ^a   Huang, Wen Yi ^a   Weiss, Jocelyn M ^a   Kaaks, Rudolf ^d   Hayes, Richard B ^a   Chanock, Stephen J ^a   Hsing, Ann W ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

androgens; genes; inflammation; single nucleotide polymorphism; testosterone

Indexed keywords

ANDROGEN; ANDROSTANEDIOL; ANDROSTENEDIONE; CD14 ANTIGEN; GELATINASE A; PROTEIN; PROTEOGLYCAN 2; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TUMOR NECROSIS FACTOR (LIGAND) SUPERFAMILY MEMBER 9; UNCLASSIFIED DRUG;

ADULT; AGED; ANDROGEN BLOOD LEVEL; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; CANCER SUSCEPTIBILITY; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; LUNG; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE; RADIOIMMUNOASSAY; SINGLE NUCLEOTIDE POLYMORPHISM; TESTOSTERONE BLOOD LEVEL;

AGED; ALLELES; ANDROGENS; ANDROSTENEDIONE; CASE-CONTROL STUDIES; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS; TESTOSTERONE;

EID: 81855182174     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21407     Document Type: Article

References (25)

1. Mantovani A, Allavena P, Sica A, Balkwill F,. Cancer-related inflammation. Nature 2008; 454: 436-444.
2. Pugh PJ, Jones RD, Jones TH, Channer KS,. Heart failure as an inflammatory condition: Potential role for androgens as immune modulators. Eur J Heart Fail 2002; 4: 673-680.
3. Maestroni GJM, Sulli A, Pizzorni C, Villaggio B, Cutolo M,. Melatonin in rheumatoid arthritis. Ann N Y Acad Sci 2002; 966: 271-275.
4. Hales DB,. Testicular macrophage modulation of Leydig cell steroidogenesis. J Reprod Immunol 2002; 57: 3-18.
5. Li B-Y, Liao X-B, Fujito A, Thrasher JB, Shen F-Y, Xu P-Y,. Dual androgen-response elements mediate androgen regulation of MMP-2 expression in prostate cancer cells. Asian J Androl 2007; 9: 41-50.
6. Wu Y, Zhao W, Zhao J, Pan J, Wu Q, Zhang Y, Bauman WA, Cardozo CP,. Identification of androgen response elements in the insulin-like growth factor I upstream promoter. Endocrinology 2007; 148: 2984-2993.
7. Qi W, Gao S, Wang Z,. Transcriptional regulation of the TGF-β1 promoter by androgen receptor. Biochem J 2008; 416: 453-462.
8. Tan JA, Marschke KB, Ho KC, Perry ST, Wilson EM, French FS,. Response elements of the androgen-regulated C3 gene. J Biol Chem 1992; 267: 4456-4466.
9. Yeager M, Orr N, Hayes RB, Jacobs KB, Kraft P, Wacholder S, Minichiello MJ, Fearnhead P, Yu K, Chatterjee N, Wang Z, Welch R, Staats BJ, Calle EE, Feigelson HS, Thun MJ, Rodriguez C, Albanes D, Virtamo J, Weinstein S, Schumacher FR, Giovannucci E, Willett WC, Cancel-Tassin G, Cussenot O, Valeri A, Andriole GL, Gelmann EP, Tucker M, Gerhard DS, Fraumeni JF Jr, Hoover R, Hunter DJ, Chanock SJ, Thomas G,. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet 2007; 39: 645-649.
10. Hayes RB, Reding D, Kopp W, Subar AF, Bhat N, Rothman N, Caporaso N, Ziegler RG, Jonhson CC, Weissfeld JL, Hoover RN, Hartge P, Palace C, Gohagan JK,. Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Control Clin Trials 2000; 21: 349S-355S.
11. Prorok PC, Andriole GL, Bresalier RS, Buys SS, Chia D, Crawford ED, Fogel R, Gelmann EP, Gilbert F, Hasson MA, Hayes RB, Johnson CC, Mandel JS, Oberman A, O'Brien B, Oken MM, Rafla S, Reding D, Rutt W, Weissfeld JL, Yokochi L, Gohagan JK,. Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials 2000; 21: 273S-309S.
12. Weiss JM, Huang WY, Rinaldi S, Fears TR, Chatterjee N, Hsing AW, Crawford ED, Andriole GL, Kaaks R, Hayes RB,. Endogenous sex hormones and the risk of prostate cancer: A prospective study. Int J Cancer 2008; 122: 2345-2350.
13. Morris PD, Malkin CJ, Channer KS, Jones TH,. A mathematical comparison of techniques to predict biologically available testosterone in a cohort of 1072 men. Eur J Endocrinol 2004; 151: 241-249.
14. Yu K, Wang Z, Li Q, Wacholder S, Hunter DJ, Hoover RN, Chanock S, Gilles T,. Population substructure and control selection in genome-wide association studies. PLoS ONE 2008; 3: e2551.
15. Yu K, Li Q, Bergen AW, Pfeiffer RM, Rosenberg PS, Caporaso N, Kraft P, Chatterjee N,. Pathway analysis by adaptive combination of P-values. Genet Epidemiol 2009; 33: 700-709.
16. Benjamini Y, Hochberg Y,. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Statist Soc B 1995; 57: 289-300.
17. Maggio M, Basaria S, Ceda GP, Ble A, Ling SM, Bandinelli S, Valenti G, Ferrucci L,. The relationship between testosterone and molecular markers of inflammation in older men. J Endocrinol Invest 2005; 28: 116-119.
18. Aderem A, Ulevitch RJ,. Toll-like receptors in the induction of the innate immune response. Nature 2000; 406: 782-787.
19. Kang YJ, Kim SO, Shimada S, Otsuka M, Seit-Nebi A, Kwon BS, Watts TH, Han J,. Cell surface 4-1BBL mediates sequential signaling pathways 'downstream' of TLR and is required for sustained TNF production in macrophages. Nat Immunol 2007; 8: 601-609.
20. Meisser A, Chardonnens D, Campana A, Bischof P,. Effects of tumour necrosis factor-a, interleukin-1 a, macrophage colony stimulating factor and transforming growth factor β on trophoblastic matrix metalloproteinases. Mol Hum Reprod 1999; 5: 252-260.
21. Qin H, Moellinger JD, Wells A, Windsor LJ, Sun Y, Benveniste EN,. Transcriptional suppression of matrix metalloproteinase-2 gene expression in human astroglioma cells by TNF-a and IFN-g. J Immunol 1998; 161: 6664-6673.
22. Ries C, Egea V, Karow M, Kolb H, Jochum M, Neth P,. MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: Differential regulation by inflammatory cytokines. Blood 2007; 109: 4055-4063.
23. Nelson AR, Fingleton B, Rothenberg ML, Matrisian LM,. Matrix metalloproteinases: Biologic activity and clinical implications. J Clin Oncol 2000; 18: 1135-1149.
24. Turpeenniemi-Hujanen T,. Gelatinases (MMP-2 and-9) and their natural inhibitors as prognostic indicators in solid cancers. Biochimie 2005; 87: 287-297.
25. Chokkalingam AP, Stanczyk FZ, Reichardt JKV, Hsing AW,. Molecular epidemiology of prostate cancer: Hormone-related genetic loci. Front Biosci 2007; 12: 3436-3460.